By Dr Priyanka Hastak

Journal articles

Hastak P; Andersen CR; Wah W; Ng SJ; Udy AA; Sasson SC; Burrell A, 2026, 'Immunocompromised patients with viral severe acute respiratory infection in intensive care: an Australia wide, retrospective, observational study', Critical Care London England, 30, http://dx.doi.org/10.1186/s13054-026-06192-6

Stadler E; Khan SR; Elias KM; Egilmezer E; Phetsouphanh C; Hastak P; Hewavisenti RV; Joshi RV; Turner T; Cromer D; Sasson SC; Davenport MP; Khoury DS, 2026, 'COVID-19 vaccine effectiveness in people on immunosuppressive therapies: a systematic review and meta-analysis', Lancet Microbe, http://dx.doi.org/10.1016/j.lanmic.2026.101424

Crammond P; Hastak P; Delaney A; Sasson SC, 2026, 'Taking its TOLL: the role of toll-like receptor 4 in human health and disease, and its potential as a therapeutic target', Frontiers in Immunology, 17, http://dx.doi.org/10.3389/fimmu.2026.1761361

Hastak P; Phetsouphanh C; Zhang ZH; Bull RA; Shrestha LB; Klemm V; Louie R; Luciani F; Munier CML; Hoppé AC; Keoshkerian E; Beaton B; Rankin K; Wong A; Trotman J; Kelleher AD; Sasson SC, 2025, 'Expanded CD16+CD56+Granzyme B+ NK like CD8+ T cells an off target effect of bruton’s tyrosine kinase inhibitors in Waldenström macroglobulinemia', Scientific Reports, 15, pp. 34641, http://dx.doi.org/10.1038/s41598-025-18450-8

Hastak P; Cromer D; Malycha J; Andersen CR; Raith E; Davenport MP; Plummer M; Sasson SC, 2024, 'Defining the correlates of lymphopenia and independent predictors of poor clinical outcome in adults hospitalized with COVID-19 in Australia', Scientific Reports, 14, pp. 11102, http://dx.doi.org/10.1038/s41598-024-61729-5

Chowdhury PR; Hastak P; DeMaere M; Wyrsch E; Li D; Elankumaran P; Dolejska M; Browning GF; Marenda MS; Gottlieb T; Cheong E; Merlino J; Myers GSA; Djordjevic SP, 2023, 'Phylogenomic analysis of a global collection of Escherichia coli ST38: evidence of interspecies and environmental transmission?', mSystems, 8, http://dx.doi.org/10.1128/msystems.01236-22

Beaton B; Sasson SC; Rankin K; Raedemaeker J; Wong A; Hastak P; Phetsouphanh C; Warden A; Klemm V; Munier CML; Hoppe AC; Tea F; Pillay A; Stella AO; Aggarwal A; Lavee O; Caterson ID; Turville S; Kelleher AD; Brilot F; Trotman J, 2023, 'Patients with treated indolent lymphomas immunized with BNT162b2 have reduced anti-spike neutralizing IgG to SARS-CoV-2 variants, but preserved antigen-specific T cell responses', American Journal of Hematology, 98, pp. 131 - 139, http://dx.doi.org/10.1002/ajh.26619

Rankin K; Hastak P; Wong A; Sasson SC; Beaton B; Yeola A; Warden A; Turville S; Kelleher AD; Brilot F; Trotman J, 2023, 'Immune response to COVID‐19 vaccination in patients with Waldenström macroglobulinaemia who pause their BTKi therapy', eJHaem, 4, pp. 728 - 732, http://dx.doi.org/10.1002/jha2.724

Hastak PS; Andersen CR; Kelleher AD; Sasson SC, 2022, 'Frontline workers: Mediators of mucosal immunity in community acquired pneumonia and COVID-19', Frontiers in Immunology, 13, http://dx.doi.org/10.3389/fimmu.2022.983550

Rankin K; Beaton B; Sasson S; Raedemaecker J; Wong A; Hastak P; Phetsouphanh C; Warden A; Patel M; Klemm V; Munier CML; Hoppe AC; Tea F; Pillay A; Ospina A; Aggarwal A; Lavee O; Caterson ID; Turville S; Kelleher AD; Brilot F; Trotman J, 2022, 'PB2087: EFFICACY OF A 3RD COVID VACCINE, INCLUDING DURING A BTKI PAUSE, IN INDIVIDUALS WITH WALDENSTRÖM MACROGLOBULINEMIA AND FOLLICULAR LYMPHOMA', HemaSphere, 6, pp. 1958 - 1959, http://dx.doi.org/10.1097/01.hs9.0000851180.32970.18

Beaton B; Sasson SC; Rankin K; Raedemaeker J; Wong A; Hastak P; Warden A; Stella AO; Aggarwal A; Caterson ID; Phetsouphanh C; Turville S; Kelleher AD; Brilot F; Trotman J, 2021, 'Efficacy of Vaccine BNT162b2 (Pfizer-BioNTech) in Individuals with Waldenstrom's Macroglobulinemia and Follicular Lymphoma in Australia', BLOOD, 138, http://dx.doi.org/10.1182/blood-2021-149348

Hastak P; Cummins ML; Gottlieb T; Cheong E; Merlino J; Myers GSA; Djordjevic SP; Chowdhury PR, 2020, 'Genomic profiling of Escherichia coli isolates from bacteraemia patients: a 3-year cohort study of isolates collected at a Sydney teaching hospital', Microbial Genomics, 6, pp. e000371 - e000371, http://dx.doi.org/10.1099/mgen.0.000371

Hastak P; Fourment M; Darling AE; Gottlieb T; Cheong E; Merlino J; Myers GSA; Djordjevic SP; Chowdhury PR, 2020, 'Escherichia coli ST8196 is a novel, locally evolved, and extensively drug resistant pathogenic lineage within the ST131 clonal complex', Emerging Microbes & Infections, 9, pp. 1780 - 1792, http://dx.doi.org/10.1080/22221751.2020.1797541

Conference Abstracts

Hewavisenti R; Zhang Z-H; Chang C; Wang T; Hastak P; Jin F; Poynten IM; Swarbrick A; Grulich AE; Kelleher A; Sasson SC, 2024, 'CD4+T-cell tissue lymphopenia in human-papillomavirus-driven anal dysplasia in people living with human immunodeficiency virus', in EUROPEAN JOURNAL OF IMMUNOLOGY, WILEY, IRELAND, Dublin, Vol. 54, pp. 522 - 522, presented at 7th European Conference of Immunology, IRELAND, Dublin, 01 September 2024 - 04 September 2024

Hastak P; Andersen CR; Zhang Z-H; Lohani A; Phetsouphanh C; van Bockel D; Shrestha S; Bass F; Hammond N; Tedla N; Kelleher A; Sasson SC, 2024, 'Delineating the immunological responses in people admitted to the ICU with direct and indirect lung injuries using single-cell RNA sequencing', in EUROPEAN JOURNAL OF IMMUNOLOGY, WILEY, IRELAND, Dublin, Vol. 54, pp. 1139 - 1139, presented at 7th European Conference of Immunology, IRELAND, Dublin, 01 September 2024 - 04 September 2024

Preprints

Stadler E; Khan SR; Elias KM; Egilmezer E; Phetsouphanh C; Hastak P; Hewavisenti RV; Joshi RV; Turner T; Cromer D; Sasson SC; Davenport MP; Khoury DS, 2026, Immunogenicity and vaccine effectiveness of COVID-19 vaccines in people on immunosuppressive therapies, http://dx.doi.org/10.64898/2026.09.16.26363194

Back to profile page